Evaluating Antiarrhythmic Drugs for Managing Infants with Supraventricular Tachycardia; a Review

Overview

Journal Am J Cardiovasc Dis

Specialty Cardiology & Vascular Diseases

Date 2024 Jul 18

PMID 39021523

Authors

Azad Mojahedi

Afsaneh Mirshekari

Affiliations

Soon will be listed here.

Abstract

Supraventricular tachycardia (SVT) is the most prevalent arrhythmia observed in infants, impacting individuals with or without congenital cardiac dysfunction. Infantile-onset SVT typically manifests within the initial one to two months of life. A variety of anti-arrhythmic medications are employed to treat SVT in infants during their first year of life. Nevertheless, a consensus has yet to be reached on the most efficacious drug, and treatment approaches continue to vary considerably As SVT remains a frequent problem around the world, with different management approaches and no obvious optimal option, we conducted a systematic review of the new update of antiarrhythmic drugs for managing SVT in infants under one year old.

References

Richardson C, Silver E . Management of Supraventricular Tachycardia in Infants. Paediatr Drugs. 2017; 19(6):539-551. DOI: 10.1007/s40272-017-0254-0. View

Bjelosevic M, Illikova V, Tomko J, Olejnik P, Chalupka M, Hatala R . Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10-year population-based study. Pacing Clin Electrophysiol. 2020; 43(7):680-686. DOI: 10.1111/pace.13964. View

Kafali H, Ergul Y . Common Supraventricular and Ventricular Arrhythmias in Children. Turk Arch Pediatr. 2022; 57(5):476-488. PMC: 9524439. DOI: 10.5152/TurkArchPediatr.2022.22099. View

Batra A, Silka M, Borquez A, Cuneo B, Dechert B, Jaeggi E . Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association: Endorsed by the Pediatric & Congenital Electrophysiology Society (PACES). Circulation. 2024; 149(10):e937-e952. DOI: 10.1161/CIR.0000000000001206. View

Krause U, Paul T, Della Bella P, Gulletta S, Gebauer R, Paech C . Pediatric catheter ablation at the beginning of the 21st century: results from the European Multicenter Pediatric Catheter Ablation Registry 'EUROPA'. Europace. 2020; 23(3):431-440. DOI: 10.1093/europace/euaa325. View

Mahtani A, Nair D . Supraventricular Tachycardia. Med Clin North Am. 2019; 103(5):863-879. DOI: 10.1016/j.mcna.2019.05.007. View

Tednes P, Marquardt S, Kuhrau S, Heagler K, Rech M . Keeping It "Current": A Review of Treatment Options for the Management of Supraventricular Tachycardia. Ann Pharmacother. 2023; 58(7):715-727. DOI: 10.1177/10600280231199136. View

Wei N, Lamba A, Franciosi S, Law I, Ochoa L, Johnsrude C . Medical Management of Infants With Supraventricular Tachycardia: Results From a Registry and Review of the Literature. CJC Pediatr Congenit Heart Dis. 2023; 1(1):11-22. PMC: 10642123. DOI: 10.1016/j.cjcpc.2021.09.001. View

Bruder D, Weber R, Gass M, Balmer C, Cavigelli-Brunner A . Antiarrhythmic Medication in Neonates and Infants with Supraventricular Tachycardia. Pediatr Cardiol. 2022; 43(6):1311-1318. PMC: 9293794. DOI: 10.1007/s00246-022-02853-9. View

10.

Lim Y, Kim Y, Kwon J . Effective Control of Supraventricular Tachycardia in Neonates May Requires Combination Pharmacologic Therapy. J Clin Med. 2022; 11(12). PMC: 9224806. DOI: 10.3390/jcm11123279. View

11.

Xinxing S, Jie Z, Lu Z, He B . The Efficacy and Safety of Radiofrequency Catheter Ablation for Cardiac Arrhythmias in Pediatric Patients. Heart Surg Forum. 2020; 23(2):E114-E117. DOI: 10.1532/hsf.2837. View

12.

Abbasi E, Vijayashankar S, Goldman R . Management of acute supraventricular tachycardia in children. Can Fam Physician. 2023; 69(12):839-841. PMC: 10949262. DOI: 10.46747/cfp.6912839. View

13.

Hill A, Silka M, Bar-Cohen Y . A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children. Pacing Clin Electrophysiol. 2019; 42(6):670-677. DOI: 10.1111/pace.13662. View

14.

Quattrocelli A, Lang J, Davis A, Pflaumer A . Age makes a difference: Symptoms in pediatric supraventricular tachycardia. J Arrhythm. 2018; 34(5):565-571. PMC: 6174476. DOI: 10.1002/joa3.12103. View

15.

Uysal F, Ozalp S, Genc A, Akca T, Turkmen H, Bostan O . Ventricular Extrasystole in Children: Single-Center Experience. Turk Arch Pediatr. 2023; 58(4):395-400. PMC: 10441151. DOI: 10.5152/TurkArchPediatr.2023.22313. View

16.

Moore J, Stephens S, Kertesz N, Evans D, Kim J, Howard T . Clinical Predictors of Recurrent Supraventricular Tachycardia in Infancy. J Am Coll Cardiol. 2022; 80(12):1159-1172. DOI: 10.1016/j.jacc.2022.06.038. View

17.

Nicastro E, Majdalani M, Abello M, Doiny D, Falconi E, Diaz C . Experience using propranolol for the management of supraventricular tachycardia in patients younger than 1 year. Arch Argent Pediatr. 2020; 118(4):273-276. DOI: 10.5546/aap.2020.eng.273. View

18.

Capponi G, Belli G, Giovannini M, Remaschi G, Brambilla A, Vannuccini F . Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre. BMC Cardiovasc Disord. 2021; 21(1):137. PMC: 7958399. DOI: 10.1186/s12872-020-01843-0. View

19.

Kornyei L, Szabo A, Roth G, Ferenci T, Kardos A . Supraventricular tachycardias in neonates and infants: factors associated with fatal or near-fatal outcome. Eur J Pediatr. 2021; 180(8):2669-2676. DOI: 10.1007/s00431-021-04159-z. View

20.

Kotadia I, Williams S, ONeill M . Supraventricular tachycardia: An overview of diagnosis and management. Clin Med (Lond). 2020; 20(1):43-47. PMC: 6964177. DOI: 10.7861/clinmed.cme.20.1.3. View